COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Saye H Khoo
Institution
University of Liverpool
Address
Liverpool
United Kingdom
vCard
Download vCard
Publication Timeline
COVID-19 publications
All Publications
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To see the data from both graphs as text,
click here
.
Year
Publications
2002
3
2003
4
2004
6
2005
5
2006
6
2007
7
2008
5
2009
2
2010
4
2011
4
2012
5
2013
7
2014
5
2015
4
2016
4
2017
1
2018
5
2020
3
2021
3
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To return to the graphs,
click here
.
Publication Field Summary
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
Publication List
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Show:
All coronarirus related publications
|
Covid-19 specific publications
|
All publications
Sort By:
Newest
|
Oldest
|
Most Cited
|
Most Discussed
PMC Citations
indicate the number of times the publication was cited by articles in PubMed Central, and the
Altmetric
score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)
Fields
are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation
tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Khoo SH
,
Fitzgerald R
,
Fletcher T
,
Ewings S
,
Jaki T
,
Lyon R
,
Downs N
,
Walker L
,
Tansley-Hancock O
,
Greenhalf W
,
Woods C
,
Reynolds H
,
Marwood E
,
Mozgunov P
,
Adams E
,
Bullock K
,
Holman W
,
Bula MD
,
Gibney JL
,
Saunders G
,
Corkhill A
,
Hale C
,
Thorne K
,
Chiong J
,
Condie S
,
Pertinez H
,
Painter W
,
Wrixon E
,
Johnson L
,
Yeats S
,
Mallard K
,
Radford M
,
Fines K
,
Shaw V
,
Owen A
,
Lalloo DG
,
Jacobs M
,
Griffiths G
. Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study. J Antimicrob Chemother. 2021 11 12; 76(12):3286-3295.
PMID:
34450619
.
Citations:
7
Fields:
Ant
Anti-Infective Agents
Translation:
Humans
Hiscox JA
,
Khoo SH
,
Stewart JP
,
Owen A
. Shutting the gate before the horse has bolted: is it time for a conversation about SARS-CoV-2 and antiviral drug resistance? J Antimicrob Chemother. 2021 08 12; 76(9):2230-2233.
PMID:
34142123
.
Citations:
1
Fields:
Ant
Anti-Infective Agents
Translation:
Humans
Animals
Pertinez H
,
Rajoli RKR
,
Khoo SH
,
Owen A
. Pharmacokinetic modelling to estimate intracellular favipiravir ribofuranosyl-5'-triphosphate exposure to support posology for SARS-CoV-2. J Antimicrob Chemother. 2021 07 15; 76(8):2121-2128.
PMID:
34075418
.
Citations:
1
Fields:
Ant
Anti-Infective Agents
Translation:
Humans
Animals
Rajoli RKR
,
Pertinez H
,
Arshad U
,
Box H
,
Tatham L
,
Curley P
,
Neary M
,
Sharp J
,
Liptrott NJ
,
Valentijn A
,
David C
,
Rannard SP
,
Aljayyoussi G
,
Pennington SH
,
Hill A
,
Boffito M
,
Ward SA
,
Khoo SH
,
Bray PG
,
O'Neill PM
,
Hong WD
,
Biagini GA
,
Owen A
. Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis. Br J Clin Pharmacol. 2021 04; 87(4):2078-2088.
PMID:
33085781
.
Citations:
14
Fields:
Pha
Pharmacology
Translation:
Humans
Penman SL
,
Kiy RT
,
Jensen RL
,
Beoku-Betts C
,
Alfirevic A
,
Back D
,
Khoo SH
,
Owen A
,
Pirmohamed M
,
Park BK
,
Meng X
,
Goldring CE
,
Chadwick AE
. Safety perspectives on presently considered drugs for the treatment of COVID-19. Br J Pharmacol. 2020 10; 177(19):4353-4374.
PMID:
32681537
.
Citations:
3
Fields:
Pha
Pharmacology
Translation:
Humans
PH
Public Health
Arshad U
,
Pertinez H
,
Box H
,
Tatham L
,
Rajoli RKR
,
Curley P
,
Neary M
,
Sharp J
,
Liptrott NJ
,
Valentijn A
,
David C
,
Rannard SP
,
O'Neill PM
,
Aljayyoussi G
,
Pennington SH
,
Ward SA
,
Hill A
,
Back DJ
,
Khoo SH
,
Bray PG
,
Biagini GA
,
Owen A
. Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics. Clin Pharmacol Ther. 2020 10; 108(4):775-790.
PMID:
32438446
.
Citations:
39
Fields:
Dru
Drug Therapy
Pha
Pharmacology
Translation:
Humans
Cells
PH
Public Health
Start with:
newest
oldest
Include:
line numbers
double spacing
all authors
publication IDs